authors
- Brunner, PM
- Conrad, C
- Vender, Ronald
- Grond, S
- Schuster, C
- Patel, H
- Xu, W
- Carrascosa Carrillo, JM
Integrated safety analysis of treatment‐emergent eczematous reactions in patients with moderate‐to‐severe psoriasis treated with ixekizumab, etanercept and ustekinumab
Journal Articles
- Overview
- Research
- Identity
- Additional Document Info
- View All
Overview
status
publication date
- October 2021
has subject area
- 1103 Clinical Sciences (FoR)
- 1112 Oncology and Carcinogenesis (FoR)
- Antibodies, Monoclonal, Humanized (MeSH)
- Dermatologic Agents (MeSH)
- Dermatology & Venereal Diseases (Science Metrix)
- Etanercept (MeSH)
- Humans (MeSH)
- Psoriasis (MeSH)
- Severity of Illness Index (MeSH)
- Treatment Outcome (MeSH)
- Ustekinumab (MeSH)
published in
- British Journal of Dermatology Journal